On Oct. 25, 2011, the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) approved recommendations for routine vaccination of males 11 or 12 years old with 3-doses of HPV4 to protect against Human Papalloma Virus (HPV).

The HPV vaccine afforded protection against certain HPV-related conditions and cancers in males, and vaccination of males with HPV may also provide indirect protection of women by reducing transmission of HPV.